<DOC>
	<DOCNO>NCT01094457</DOCNO>
	<brief_summary>Clopidogrel resistance ( CR ) low-responsiveness associate increase risk ischemic event detect laboratory test . This multicenter , randomize study aim explore efficacy safety intensive antiplatelet therapy ( i.e . double clopidogrel maintenance dose and/or additional cilostazol ) patient CR coronary stenting .</brief_summary>
	<brief_title>Effects Intensive Antiplatelet Therapy Patients With Clopidogrel Resistance After Coronary Stent Implantation</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Inclusion Criterial : age 35 75 year acute coronary syndrome underwent successful coronary stent implantation inform consent contraindication antiplatelet therapy history intracranial bleeding know bleed disorder severe liver kidney disease pregnancy leave main coronary artery disease plan non cardiac surgery within 1 year end stage serious disease life expectancy le 1 year heart failure NYHA grade 3 4</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>antiplatelet therapy</keyword>
	<keyword>clopidogrel low responsiveness</keyword>
	<keyword>acute coronary syndrome</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>cilostazol</keyword>
</DOC>